AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34459211 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2571
Study 32321492 — intervention group
Group type: EXPERIMENTAL
Intervention: e-Exercise LBP
Number of subjects: 208
Study 32321492 — intervention group
Group type: COMPARATOR
Intervention: usual care physiotherapy
Number of subjects: 208
Study 35962334 — intervention group
Group type: EXPERIMENTAL
Intervention: One Session Treatment (OST)
Number of subjects: 267
Study 35962334 — intervention group
Group type: COMPARATOR
Intervention: Multi-session Cognitive Behavioural Therapy (CBT)
Number of subjects: 267
Study 33591860 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrochemotherapy (ECT) with intratumoral bleomycin (n = 9)
Number of subjects: 21
Study 33591860 — intervention group
Group type: COMPARATOR
Intervention: Standard surgical resection and reconstruction (control; n = 12)
Number of subjects: 21
Study 33591860 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrochemotherapy (ECT)
Number of subjects: 21
Study 32729897 — intervention group
Group type: COMPARATOR
Intervention: Ranibizumab 0.5 mg every 4 weeks
Number of subjects: 76
Study 32729897 — intervention group
Group type: EXPERIMENTAL
Intervention: Faricimab 6.0 mg every 12 weeks
Number of subjects: 76
Study 32729897 — intervention group
Group type: EXPERIMENTAL
Intervention: Faricimab 6.0 mg every 16 weeks
Number of subjects: 76
Study 32729897 — intervention group
Group type: EXPERIMENTAL
Intervention: Faricimab (both dosing schedules)
Number of subjects: 76
Study 36420523 — intervention group
Group type: EXPERIMENTAL
Intervention: Maqui berry-based nutraceutical (MBN) supplementation, 1,000 mg/day for 30 days
Number of subjects: 30
Study 36420523 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 30
Study 34688257 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital-supervised exercise interventions
Number of subjects: 28
Study 34688257 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise interventions
Number of subjects: 28
Study 34688257 — intervention group
Group type: COMPARATOR
Intervention: Standard care exercise advice
Number of subjects: 28
Study 35270426 — intervention group
Group type: EXPERIMENTAL
Intervention: Future-oriented financial coaching
Number of subjects: 251
Study 35270426 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 251
Study 32213475 — intervention group
Group type: EXPERIMENTAL
Intervention: Photography education
Number of subjects: 60
Study 32213475 — intervention group
Group type: COMPARATOR
Intervention: Photos taken by dentists
Number of subjects: 60
Study 32213475 — intervention group
Group type: COMPARATOR
Intervention: iPhone 6
Number of subjects: 60
Study 36215815 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management education and support intervention (8 sessions of 90 minutes each, followed by a 3-month follow-up)
Number of subjects: 70
Study 36215815 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study 33789433 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and education program (12 weeks, 8 supervised exercise sessions and 3 one-on-one sessions)
Number of subjects: 111
Study 33789433 — intervention group
Group type: COMPARATOR
Intervention: Education booklet (control)
Number of subjects: 111
Study 33789433 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and education program (12 weeks)
Number of subjects: 111
Study 32406284 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal creams (Centella asiatica, Cucumis sativus, Thunbergia laurifolia) and commercial moisturizing cream
Number of subjects: 153
Study 32406284 — intervention group
Group type: EXPERIMENTAL
Intervention: Cucumis sativus cream
Number of subjects: 153
Study 32406284 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 153
Study 34860138 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 59
Study 34860138 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 34626004 — intervention group
Group type: EXPERIMENTAL
Intervention: PERT prior to meals
Number of subjects: 30
Study 34626004 — intervention group
Group type: COMPARATOR
Intervention: PERT after meals
Number of subjects: 30
Study 32041861 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief self-compassion intervention delivered in a group format over two sessions
Number of subjects: 0
Study 32041861 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 0
Study 36073143 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide
Number of subjects: 9901
Study 36073143 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9901
Study 35164729 — intervention group
Group type: EXPERIMENTAL
Intervention: Play Active physical activity policy intervention
Number of subjects: 60
Study 35164729 — intervention group
Group type: COMPARATOR
Intervention: Wait-listed comparison condition
Number of subjects: 60
Study 33314183 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructan diet
Number of subjects: 38
Study 33314183 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin diet
Number of subjects: 38
Study 33314183 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline comparison
Number of subjects: 38
Study 35101016 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence-based teaching formats without patient contact
Number of subjects: 102
Study 35101016 — intervention group
Group type: COMPARATOR
Intervention: Presence-based teaching formats with patient contact
Number of subjects: 102
Study 33239941 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue flossing
Number of subjects: 17
Study 33239941 — intervention group
Group type: COMPARATOR
Intervention: Dynamic stretching (DS)
Number of subjects: 17
Study 33239941 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 17
Study 33802260 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES with exercise (EX + NMES)
Number of subjects: 30
Study 33802260 — intervention group
Group type: COMPARATOR
Intervention: Exercise only (EX)
Number of subjects: 30
Study 33802260 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 30
Study 32962673 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection into the wound at 4 and 12 postoperative days
Number of subjects: 100
Study 32962673 — intervention group
Group type: COMPARATOR
Intervention: Regular dressing postoperatively
Number of subjects: 100
Study 35179573 — intervention group
Group type: EXPERIMENTAL
Intervention: Dream Changer intervention
Number of subjects: 56
Study 35179573 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 56
Study 33800789 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing concentrations of sucrose added to chocolate pudding base
Number of subjects: 1208
Study 33800789 — intervention group
Group type: EXPERIMENTAL
Intervention: High and Moderate Sweet Likers
Number of subjects: 1208
Study 33800789 — intervention group
Group type: EXPERIMENTAL
Intervention: Inverted U-Shaped cluster
Number of subjects: 1208
Study 32127657 — intervention group
Group type: EXPERIMENTAL
Intervention: Plerixafor + standard mobilization (G‐CSF ± chemotherapy)
Number of subjects: 45
Study 32127657 — intervention group
Group type: COMPARATOR
Intervention: Standard mobilization alone
Number of subjects: 45
Study 36096929 — intervention group
Group type: EXPERIMENTAL
Intervention: Visceral fat area (VFA)
Number of subjects: 2116
Study 36096929 — intervention group
Group type: EXPERIMENTAL
Intervention: High visceral fat area (VFA)
Number of subjects: 2116
Study 36096929 — intervention group
Group type: EXPERIMENTAL
Intervention: Age, BMI, hypertension, dyslipidemia, total fat area (TFA), visceral fat area (VFA), visceral‐to‐subcutaneous fat ratio (VSR), waist circumference (WC)
Number of subjects: 2116
Study 36096929 — intervention group
Group type: COMPARATOR
Intervention: BMI, TFA, SFA, VSR, WC
Number of subjects: 2116
Study 33554255 — intervention group
Group type: EXPERIMENTAL
Intervention: Driver ablation
Number of subjects: 124
Study 33554255 — intervention group
Group type: COMPARATOR
Intervention: Conventional ablation
Number of subjects: 124
Study 32559003 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenograft A
Number of subjects: 16
Study 32559003 — intervention group
Group type: COMPARATOR
Intervention: Xenograft B
Number of subjects: 16
Study 32559003 — intervention group
Group type: EXPERIMENTAL
Intervention: Both xenografts
Number of subjects: 16
Study 34374330 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy intervention (4 sessions per week for 4 weeks, totaling 16 sessions)
Number of subjects: 80
Study 32907792 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (LI) focused on physical activity
Number of subjects: 74
Study 32907792 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 74
Study 32014311 — intervention group
Group type: EXPERIMENTAL
Intervention: Test group with individualized protamine titration based on ACT measurements
Number of subjects: 138
Study 32014311 — intervention group
Group type: COMPARATOR
Intervention: Control group with standard protamine infusion of 1.3 mg per 1 mg (100 U) of heparin
Number of subjects: 138
Study 32014311 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 138
Study 32205019 — intervention group
Group type: EXPERIMENTAL
Intervention: High-grade PI retrolisthesis
Number of subjects: 887
Study 32205019 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-grade PI retrolisthesis
Number of subjects: 887
Study 32205019 — intervention group
Group type: COMPARATOR
Intervention: Control group (no lumbar spondylolisthesis)
Number of subjects: 887
Study 34464242 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol (Bud + Form; 400/12 µg BID)
Number of subjects: 63
Study 34464242 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone/salmeterol (Flu + Salm; 250/50 µg BID)
Number of subjects: 63
Study 34464242 — intervention group
Group type: COMPARATOR
Intervention: Formoterol only (Form; 12 µg BID)
Number of subjects: 63
Study 35638262 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Number of subjects: 0
Study 34382504 — intervention group
Group type: EXPERIMENTAL
Intervention: MBF Child Safety Matters (CSM) curriculum
Number of subjects: 2414
Study 34382504 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (no intervention)
Number of subjects: 2414
Study 32711460 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary care records
Number of subjects: 2811
Study 36179772 — intervention group
Group type: EXPERIMENTAL
Intervention: Good adherence to OACs (PDC >80%)
Number of subjects: 778
Study 36179772 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin K antagonists (VKAs) among adherent patients
Number of subjects: 778
Study 36179772 — intervention group
Group type: COMPARATOR
Intervention: Direct oral anticoagulants (DOACs) among adherent patients
Number of subjects: 778
Study 33851966 — intervention group
Group type: EXPERIMENTAL
Intervention: NP202, 1000 mg, daily for 3 months
Number of subjects: 147
Study 33851966 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study 33851966 — intervention group
Group type: EXPERIMENTAL
Intervention: NP202
Number of subjects: 147
Study 35534822 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified physiotherapy program (endurance and muscle force exercises using cycle ergometer)
Number of subjects: 56
Study 35534822 — intervention group
Group type: COMPARATOR
Intervention: Control group (physiotherapy limited to hospital stay, 20 min on 5 days per week)
Number of subjects: 56
Study 35921262 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived choice in music (intervention group)
Number of subjects: 286
Study 35921262 — intervention group
Group type: COMPARATOR
Intervention: No choice in music (control group)
Number of subjects: 286
Study 35921262 — intervention group
Group type: EXPERIMENTAL
Intervention: High complexity music (intervention group)
Number of subjects: 286
Study 35921262 — intervention group
Group type: COMPARATOR
Intervention: Low complexity music (control group)
Number of subjects: 286
Study 33023589 — intervention group
Group type: EXPERIMENTAL
Intervention: Outreach case management for 12 months
Number of subjects: 60
Study 35064715 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based multi-month dispensing (MMD) of antiretroviral treatment (ART) with options for 3-monthly or 6-monthly dispensing.
Number of subjects: 20
Study 35064715 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based multi-month dispensing (MMD) of ART
Number of subjects: 20
Study 33957389 — intervention group
Group type: COMPARATOR
Intervention: Vinpocetine 10 mg oral
Number of subjects: 16
Study 33957389 — intervention group
Group type: COMPARATOR
Intervention: Vinpocetine 20 mg oral
Number of subjects: 16
Study 33957389 — intervention group
Group type: COMPARATOR
Intervention: Vinpocetine 60 mg oral
Number of subjects: 16
Study 33957389 — intervention group
Group type: COMPARATOR
Intervention: Vinpocetine 20 mg oral three times a day (one-month open label)
Number of subjects: 16
Study 33957389 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 36079139 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (n = 60)
Number of subjects: 120
Study 36079139 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS (n = 60)
Number of subjects: 120
Study 35187731 — intervention group
Group type: COMPARATOR
Intervention: Guided Bone Regeneration (GBR)
Number of subjects: 42
Study 35187731 — intervention group
Group type: EXPERIMENTAL
Intervention: Connective Tissue Graft (CTG)
Number of subjects: 42
Study 33136159 — intervention group
Group type: EXPERIMENTAL
Intervention: Caspofungin
Number of subjects: 290
Study 33136159 — intervention group
Group type: COMPARATOR
Intervention: Triazole (Fluconazole)
Number of subjects: 290
Study 33136159 — intervention group
Group type: COMPARATOR
Intervention: Triazole (Voriconazole)
Number of subjects: 290
Study 32403130 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week intensive intervention comprising lifestyle approaches and treatment with insulin glargine, metformin, and dapagliflozin
Number of subjects: 154
Study 32403130 — intervention group
Group type: COMPARATOR
Intervention: Standard diabetes care
Number of subjects: 154
Study 35441559 — intervention group
Group type: EXPERIMENTAL
Intervention: US transducer-guided radial artery puncture technology with guide marks on the side of the US transducer probe
Number of subjects: 127
Study 35441559 — intervention group
Group type: COMPARATOR
Intervention: Conventional US transducer-guided radial artery puncture technology
Number of subjects: 127
Study 32146619 — intervention group
Group type: EXPERIMENTAL
Intervention: Telotristat ethyl 250 mg tid
Number of subjects: 69
Study 32146619 — intervention group
Group type: EXPERIMENTAL
Intervention: Telotristat ethyl 500 mg tid
Number of subjects: 69
Study 32680487 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-track pathway for MRI scan and spinal specialist opinion
Number of subjects: 40
Study 33663316 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapoxetine taste-masked oral thin films (OTFs) with pullulan, glycerol, AmberLite, and dapoxetine (30 mg)
Number of subjects: 0
Study 616870332 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 562
Study 616870332 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 562
Study 616870332 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus with concomitant octreotide
Number of subjects: 562
Study 36381457 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-saline (HS) irrigation solution
Number of subjects: 61
Study 36381457 — intervention group
Group type: COMPARATOR
Intervention: Normal-saline (NS) irrigation solution
Number of subjects: 61
Study 36381457 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-saline (HS) and Normal-saline (NS)
Number of subjects: 61
Study 33257672 — intervention group
Group type: EXPERIMENTAL
Intervention: FLOT regimen (4 cycles of docetaxel, oxaliplatin, fluorouracil, and leucovorin)
Number of subjects: 74
Study 33257672 — intervention group
Group type: COMPARATOR
Intervention: SOX regimen (3 cycles of tegafur gimeracil oteracil potassium capsule plus oxaliplatin)
Number of subjects: 74
Study 36469329 — intervention group
Group type: EXPERIMENTAL
Intervention: Full remediation (installing working windows and doors, cleaning trash, weeding)
Number of subjects: 301
Study 36469329 — intervention group
Group type: EXPERIMENTAL
Intervention: Trash cleanup and weeding only
Number of subjects: 301
Study 36469329 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing remediation or trash cleanup treatment
Number of subjects: 301
Study 36469329 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control
Number of subjects: 301
Study 33961292 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose cytosine arabinoside (LDAC) plus tosedostat (LDAC-T)
Number of subjects: 243
Study 33961292 — intervention group
Group type: COMPARATOR
Intervention: Low-dose cytosine arabinoside (LDAC)
Number of subjects: 243
Study 32965235 — intervention group
Group type: EXPERIMENTAL
Intervention: everyBody Plus web-based cognitive behavioral intervention
Number of subjects: 116
Study 33622544 — intervention group
Group type: EXPERIMENTAL
Intervention: Cast clasps in a 0.25-mm undercut
Number of subjects: 60
Study 33622544 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrought round wire of 1-mm diameter
Number of subjects: 60
Study 34213773 — intervention group
Group type: EXPERIMENTAL
Intervention: Tri-layer nitrile-latex gloves
Number of subjects: 46
Study 34213773 — intervention group
Group type: COMPARATOR
Intervention: Natural rubber latex gloves
Number of subjects: 46
Study 34213773 — intervention group
Group type: COMPARATOR
Intervention: Unused gloves
Number of subjects: 46
Study 34942105 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 0.05%
Number of subjects: 314
Study 34942105 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 0.025%
Number of subjects: 314
Study 34942105 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine 0.01%
Number of subjects: 314
Study 33996039 — intervention group
Group type: EXPERIMENTAL
Intervention: Interviewer-administered seven-day semi-quantitative food frequency questionnaire (7-d SQFFQ)
Number of subjects: 105
Study 32321570 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX) before release
Number of subjects: 0
Study 32321570 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced XR-NTX (mobile medical treatment post-release)
Number of subjects: 0
Study 32321570 — intervention group
Group type: COMPARATOR
Intervention: XR-NTX (standard referral to community treatment program post-release)
Number of subjects: 0
Study 34739763 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean Arterial Pressure (MAP)
Number of subjects: 3428
Study 34739763 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse Pressure
Number of subjects: 3428
Study 34739763 — intervention group
Group type: COMPARATOR
Intervention: MAP and Pulse Pressure (both groups)
Number of subjects: 3428
Study 32947547 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized acupuncture
Number of subjects: 896
Study 32947547 — intervention group
Group type: COMPARATOR
Intervention: Shallow acupuncture
Number of subjects: 896
Study 32947547 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 896
Study 32507439 — intervention group
Group type: EXPERIMENTAL
Intervention: Garlic powder supplementation (400 mg per tablet, 4 tablets daily for 12 weeks)
Number of subjects: 90
Study 32507439 — intervention group
Group type: COMPARATOR
Intervention: Placebo (400 mg starch per tablet, 4 tablets daily for 12 weeks)
Number of subjects: 90
Study 34344230 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity aerobic training
Number of subjects: 76
Study 34344230 — intervention group
Group type: COMPARATOR
Intervention: High-intensity aerobic training
Number of subjects: 76
Study 34323454 — intervention group
Group type: EXPERIMENTAL
Intervention: Sphenopalatine ganglion block (SPGB) in treatment group A
Number of subjects: 123
Study 34323454 — intervention group
Group type: COMPARATOR
Intervention: Control group B (no PDPH)
Number of subjects: 123
Study 32487971 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk stability exercise wearing a pelvic belt on the paretic side
Number of subjects: 36
Study 32487971 — intervention group
Group type: EXPERIMENTAL
Intervention: Trunk stability exercise wearing a pelvic belt on the nonparetic side
Number of subjects: 36
Study 32487971 — intervention group
Group type: COMPARATOR
Intervention: Trunk stability exercise without a pelvic belt (control group)
Number of subjects: 36
Study 34737187 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (1.8 mg daily for 5 weeks after 2 weeks of titration)
Number of subjects: 76
Study 34737187 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 33621253 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide + salbutamol
Number of subjects: 6396
Study 33621253 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol alone
Number of subjects: 6396
Study 33856948 — intervention group
Group type: EXPERIMENTAL
Intervention: Wire Localization (WL)
Number of subjects: 631
Study 33856948 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioactive Seed (RS)
Number of subjects: 631
Study 33856948 — intervention group
Group type: EXPERIMENTAL
Intervention: Savi Scout (SS)
Number of subjects: 631
Study 33382406 — intervention group
Group type: EXPERIMENTAL
Intervention: START-Play intervention plus usual care early intervention (UC-EI)
Number of subjects: 112
Study 33382406 — intervention group
Group type: COMPARATOR
Intervention: Usual care early intervention (UC-EI)
Number of subjects: 112
Study 34016825 — intervention group
Group type: EXPERIMENTAL
Intervention: Centrifuged adipose tissue injection
Number of subjects: 116
Study 34016825 — intervention group
Group type: COMPARATOR
Intervention: No injection of centrifuged adipose tissue (control)
Number of subjects: 116
Study 34521135 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided continuous thoracic paravertebral block (UG-TPVB)
Number of subjects: 128
Study 34521135 — intervention group
Group type: COMPARATOR
Intervention: Conventional patient-controlled analgesia (PCA)
Number of subjects: 128
Study 35085839 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 40
Study 35085839 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study 33196797 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI reporting (group 1)
Number of subjects: 28641